These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9291162)
1. Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies? van Schaik IN; Vermeulen M; Brand A Mult Scler; 1997 Apr; 3(2):98-104. PubMed ID: 9291162 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth. Tzekova N; Heinen A; Bunk S; Hermann C; Hartung HP; Reipert B; Küry P J Neuroinflammation; 2015 May; 12():107. PubMed ID: 26022648 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. van Engelen BG; Pavelko KD; Rodriguez M Mult Scler; 1997 Apr; 3(2):76-9. PubMed ID: 9291157 [TBL] [Abstract][Full Text] [Related]
5. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination. Stangel M; Bernard D J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
7. B cells are resistant to immunomodulation by 'IVIg-educated' dendritic cells. Maddur MS; Hegde P; Sharma M; Kaveri SV; Bayry J Autoimmun Rev; 2011 Dec; 11(2):154-6. PubMed ID: 21864723 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies. Comi G; Nemni R; Amadio S; Galardi G; Leocani L Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609 [TBL] [Abstract][Full Text] [Related]
11. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells. Issekutz AC; Rowter D; Miescher S; Käsermann F Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases. Stangel M; Toyka KV; Gold R Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303 [TBL] [Abstract][Full Text] [Related]
16. A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg). Pashov A; Bellon B; Kaveri SV; Kazatchkine MD Mult Scler; 1997 Apr; 3(2):153-6. PubMed ID: 9291172 [TBL] [Abstract][Full Text] [Related]
17. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology. Zawadzka M; Franklin RJ Curr Opin Neurol; 2007 Jun; 20(3):294-8. PubMed ID: 17495623 [TBL] [Abstract][Full Text] [Related]
18. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg). Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165 [TBL] [Abstract][Full Text] [Related]